166 related articles for article (PubMed ID: 12393502)
21. Immunoglobulins D and M multiple myeloma variants are heavily mutated.
Juge-Morineau N; Heirman C; Bakkus M; Van Camp B; Malfait R; Harousseau JL; Thielemans K; Bataille R
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2501-6. PubMed ID: 9815653
[TBL] [Abstract][Full Text] [Related]
22. t(11;14) Plasma cell disorder presents as a true nonsecretory, nonproducer multiple myeloma.
Chen W; Namara MM; Kim Y; Huang Q
Clin Lymphoma Myeloma; 2009 Jun; 9(3):243-6. PubMed ID: 19525195
[TBL] [Abstract][Full Text] [Related]
23. Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases.
Fonseca R; Witzig TE; Gertz MA; Kyle RA; Hoyer JD; Jalal SM; Greipp PR
Br J Haematol; 1998 May; 101(2):296-301. PubMed ID: 9609525
[TBL] [Abstract][Full Text] [Related]
24. Nonrandom rearrangement of chromosome 14 at band q32.33 in human lymphoid malignancies with mature B-cell phenotype.
Nishida K; Taniwaki M; Misawa S; Abe T
Cancer Res; 1989 Mar; 49(5):1275-81. PubMed ID: 2492904
[TBL] [Abstract][Full Text] [Related]
25. Fluorescence in situ hybridization analysis of immunoglobulin heavy chain translocations in plasma cell myeloma using intact paraffin sections and simultaneous CD138 immunofluorescence.
Cook JR; Hartke M; Pettay J; Tubbs RR
J Mol Diagn; 2006 Sep; 8(4):459-65. PubMed ID: 16931586
[TBL] [Abstract][Full Text] [Related]
26. IgM myeloma with t(4;14)(p16;q32).
Ackroyd S; O'Connor SJ; Rawstron AC; Owen RG
Cancer Genet Cytogenet; 2005 Oct; 162(2):183-4. PubMed ID: 16213370
[No Abstract] [Full Text] [Related]
27. The t(11;14)(q13;q32) translocation as a poor prognostic parameter for autologous stem cell transplantation in myeloma patients with extramedullary plasmacytoma.
Shin HJ; Kim K; Lee JJ; Song MK; Lee EY; Park SH; Kim SH; Jang MA; Kim SJ; Chung JS
Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):227-35. PubMed ID: 25812994
[TBL] [Abstract][Full Text] [Related]
28. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14).
Cook JR; Aguilera NI; Reshmi-Skarja S; Huang X; Yu Z; Gollin SM; Abbondanzo SL; Swerdlow SH
Hum Pathol; 2004 Apr; 35(4):447-54. PubMed ID: 15116325
[TBL] [Abstract][Full Text] [Related]
29. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N
Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791
[TBL] [Abstract][Full Text] [Related]
30. Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.
Nagy Z; Kajtár B; Jáksó P; Dávid M; Kosztolányi S; Hermesz J; Kereskai L; Pajor L; Alpár D
Leuk Res; 2011 Aug; 35(8):1114-6. PubMed ID: 21377730
[TBL] [Abstract][Full Text] [Related]
31. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
[TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 expression in patients with multiple myeloma.
Troussard X; Avet-Loiseau H; Macro M; Mellerin MP; Malet M; Roussel M; Sola B
Hematol J; 2000; 1(3):181-5. PubMed ID: 11920187
[TBL] [Abstract][Full Text] [Related]
33. Rarity of IgH translocations in Waldenström macroglobulinemia.
Ackroyd S; O'Connor SJ; Owen RG
Cancer Genet Cytogenet; 2005 Nov; 163(1):77-80. PubMed ID: 16271961
[TBL] [Abstract][Full Text] [Related]
34. The utility of interphase fluorescence in situ hybridization for the detection of the translocation t(11;14)(q13;q32) in the diagnosis of mantle cell lymphoma on fine-needle aspiration specimens.
Caraway NP; Gu J; Lin P; Romaguera JE; Glassman A; Katz R
Cancer; 2005 Apr; 105(2):110-8. PubMed ID: 15712276
[TBL] [Abstract][Full Text] [Related]
35. The establishment of an interleukin-6-dependent myeloma cell line (FLAM-76) carrying t(11;14)(q13;q32) chromosome abnormality from an aggressive nonsecretory plasma cell leukemia.
Kubonishi I; Seto M; Shimamura T; Enzan H; Miyoshi I
Cancer; 1992 Sep; 70(6):1528-35. PubMed ID: 1516003
[TBL] [Abstract][Full Text] [Related]
36. IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WM.
Bazarbachi AH; Avet-Loiseau H; Szalat R; Samur AA; Hunter Z; Shammas M; Corre J; Fulciniti M; Anderson KC; Parmigiani G; Treon SP; Mohty M; Munshi NC; Samur MK
Blood; 2021 Nov; 138(20):1980-1985. PubMed ID: 34792571
[TBL] [Abstract][Full Text] [Related]
37. [Nonsecretory myeloma with t(14;18)(q32;21) chromosome abnormality].
Fujii H; Maekawa T; Kanoh T; Ohnaka T; Kamezaki H; Nishida K; Urata Y
Rinsho Ketsueki; 1987 Apr; 28(4):601-7. PubMed ID: 3626051
[No Abstract] [Full Text] [Related]
38. Double-hit myeloma with IGH/MYC and IGH/CCND1 translocations.
Ji M; Jang S; Lee JH; Seo EJ
Ann Hematol; 2013 Aug; 92(8):1129-31. PubMed ID: 23307601
[No Abstract] [Full Text] [Related]
39. 11q13 rearrangement in B cell chronic lymphocytic leukemia.
Brizard F; Dreyfus B; Guilhot F; Tanzer J; Brizard A
Leuk Lymphoma; 1997 May; 25(5-6):539-43. PubMed ID: 9250825
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).
Pruneri G; Fabris S; Baldini L; Carboni N; Zagano S; Colombi MA; Ciceri G; Lombardi L; Rocchi M; Buffa R; Maiolo AT; Neri A
Am J Pathol; 2000 May; 156(5):1505-13. PubMed ID: 10793062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
